Krystal Biotech Inc (KRYS)

Financial leverage ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Total assets US$ in thousands 1,055,840 982,318 917,658 853,296 818,355 790,350 684,026 531,847 558,450 576,379 601,324 616,874 626,295 451,095 443,556 443,018 310,844 311,451 318,145 205,131
Total stockholders’ equity US$ in thousands 946,380 885,846 838,893 799,242 778,641 755,948 653,114 489,566 522,231 540,772 559,181 548,554 593,576 408,237 418,540 430,652 292,084 301,720 309,696 198,369
Financial leverage ratio 1.12 1.11 1.09 1.07 1.05 1.05 1.05 1.09 1.07 1.07 1.08 1.12 1.06 1.10 1.06 1.03 1.06 1.03 1.03 1.03

December 31, 2024 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,055,840K ÷ $946,380K
= 1.12

The financial leverage ratio of Krystal Biotech Inc has shown some fluctuations over the reported periods, ranging from 1.03 to 1.12. This ratio indicates the extent to which the company relies on debt to finance its operations and growth. A higher financial leverage ratio suggests that a larger proportion of the company's assets are funded by debt rather than equity.

Specifically, the company's financial leverage ratio increased from 1.03 in March 2020 to 1.12 in December 2024, signifying a potential increase in the company's debt levels relative to its equity over this period. However, the ratio has displayed some variability over the quarters, reaching a peak in March 2024 at 1.12.

It is important for investors and analysts to closely monitor the financial leverage ratio of Krystal Biotech Inc to assess the company's risk exposure, ability to meet debt obligations, and overall financial health. A high or increasing leverage ratio could indicate higher financial risk, while a decreasing ratio may signal improved financial stability and efficiency in capital structure management.